A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global I.V. Iron Drugs Market by Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others), By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Brazil, South Africa).
Over the recent years, the global Intravenous (IV) Iron Drug industry has been driven by the rising high prevalence of Iron Deficiency with unfulfilled need, rising awareness, growing prevalence of diseases leading to severe Iron Deficiency and increasing healthcare expenditure in emerging economies. Globally, the growth in IV Iron drug market is driven by growing middle class population group demanding better drugs to improve lifestyle.
According to Azoth Analytics research report, “Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others), By Product Type (Ferric Carboxymaltose, Iron Sucrose, Iron Dextran, Others) - By Region, By Country (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 11.19% by value during 2017 – 2022, chiefly driven by increase in healthcare spending and rising prevalence of diseases with Iron deficiency, emerging second & third generation IV Iron drugs and growing middle class income group coupled with rising health consciousness.
Among the therapeutic application type, nephrology accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with Iron Deficiency and unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.
Request a Free Sample of The Report: http://orbisresearch.com/contacts/request-sample/2054795
The report titled, “Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others), By Product Type (Ferric Carboxymaltose, Iron Sucrose, Iron Dextran, Others) - By Region, By Country (2017-2022)” has covered and analysed the potential of IV Iron Drug Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global IV Iron Drug market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
Global IV Iron Drug Market, By Value
By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value
Regional Markets – North America, Europe, APAC, and ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value
Country Analysis - United States, Canada, United Kingdom, Germany, France, China, India, Japan, Brazil and South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value
Other Report Highlights
Market Dynamics – Trends, Drivers, Challenges, Policy and Regulation
Company Analysis – Galenica; AMAG Pharmaceuticals, Inc; PHARMACOSMOS A/S; Allergan PLC; DAIICHI SANKYO COMPANY, LIMITED; NIPPON SHINYAKU CO., LTD and Sanofi
Buy The Report@http://orbisresearch.com/contact/purchase/2054795
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Major Points From The Table Of Contents:
Research Methodology
Executive Summary
Strategic Recommendations
I.V. Iron Drug Market Outlook
Global I.V. Iron Drug Market: Growth and Forecast
Market Dynamics
Market Restraints
SWOT Analysis – I.V. Iron Drug Market
Porter’s Five Forces Analysis – I.V. Iron Drug Market
Policy and Regulations
Company Profiles
List of Figures
Figure 1: Causes of premature (under age 70) NCD mortality, 2017 (%)
Figure 2: Global I.V. Iron Drug Market Size, By Value, 2012-2016 (USD Million)
Figure 3: World Population 65 Years & Above (% of Total), 2012-2016
Figure 4: Life Expectancy at birth rate (Years), 2012-2015
Figure 5: Global Life expectancy at birth, total (years) 2012 -2015
Figure 6: World Female Population, 2012-2016
Figure 7: Global Healthcare Expenditure, 2012-2016 (In Trillion)
Figure 8: Global Potential Patients Numbers, All Indications 2017 (In Million)
Figure 9: Global I.V. Iron Drug Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 10: Global I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
Figure 11: Global I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
Figure 12: Global I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
Figure 13: Worldwide Dialysis Patients, Numbers (In Million), 2010, 2015, 2020
Figure 14: Global I.V. Iron Drug Market- By Product Type, By Value, 2012-2022 (USD Million)
Figure 15: Global I.V. Iron Drug Market- By Product Type, By Value, 2012-2022 (USD Million)
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello, Senior Manager – Client Engagements
Email:Send Email
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://orbisresearch.com/reports/index/global-intravenous-iv-iron-drugs-market-analysis-by-therapeutic-application-by-product-type-by-region-by-country-2018-edition-forecast-to-2022
